Clinical trial Recruiting at 2 sites Interventional Ages 18 to 55

Comparing two methods for fixing knee ligament grafts

Official title: A Prospective Randomized Controlled Trial Comparing the Endobutton CL BTB Fixation System With Metal Interference Screws in the Femoral Fixation of Patellar Tendon Grafts in Anterior Cruciate Ligament Reconstruction.

Run by St. Olavs Hospital · NCT02918734 · Data updated 2026-11-12

This study is testing which method of fixing knee ligament grafts works better for people getting ACL surgery, comparing a special button system to metal screws.

Quick facts

Study typeInterventional
Ages18 Years to 55 Years
SexAll
Enrollment220 (estimated)
SponsorSt. Olavs Hospital
Academic / other
Locations2 sites (Trondheim and 1 other locations)
StatusRecruiting
StartedOctober 2016
Main results expectedDecember 2026
Study endsMarch 2033
Registry record updatedJuly 20, 2026
Trial IDNCT02918734 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals undergoing primary ACL reconstruction with a bone-patellar tendon-bone autograft.

Probably not a fit

Patients with previous major knee surgeries or those requiring different graft types due to medical indications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the outcomes of two different fixation methods for bone-patellar tendon-bone autografts used in anterior cruciate ligament (ACL) reconstruction. Patients will be randomly assigned to receive either the Endobutton CL BTB Fixation System or metal interference screws for femoral fixation. The study will assess various outcomes, including patient-reported results, knee laxity, range of motion, and muscle strength, with a primary focus on knee-related quality of life two years post-surgery. This is the first randomized controlled trial to directly compare these two fixation techniques.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical outcomes and recovery for patients undergoing ACL reconstruction.

How similar studies have gone: While the Endobutton fixation method has shown promising results in other contexts, this specific comparison has not been previously tested in randomized controlled trials.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Primary reconstruction of ACL ruptures
* Surgery at least 6 weeks after injury
* The patient must accept and sign the informed consent form before surgery

Exclusion Criteria:

* Medical indication for using another graft than BPTB autograft (such as history of anterior knee pain or occupations etc. requiring frequent kneeling)
* Previous major surgical procedures in the same knee
* Major additional injuries in the knee (posterior cruciate ligament, lateral collateral ligament, medial collateral ligament, sutured meniscus lesions and major cartilage lesions undergoing cartilage repair)
* Contralateral ACL injury (treated or untreated)
* Present or former serious illness that makes follow-up or rehabilitation difficult (e.g. alcohol or drug abuse, psychiatric disease)

Where it's running

  • Department of Orthopedic Surgery, St Olavs Hospital
    Trondheim, Norway
    Recruiting
  • Rosenborgklinikken
    Trondheim, Norway
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.